Tag: cardiovascular innovation

Boston Scientific Announces Strategic Investment in MiRus LLC

Boston Scientific announced a $1.5 billion investment in MiRus LLC to support…

ME Desk

Lilly to acquire Verve Therapeutics to advance one-time treatments for people with high cardiovascular risk

Eli Lilly and Company and Verve Therapeutics, Inc., a Boston-based clinical-stage company…

ME Desk